{"schema_version":"secwatch.filing_event.v1","accession":"0000012208-23-000058","form_type":"8-K","ticker":"BIO","cik":"0000012208","company_name":"BIO-RAD LABORATORIES, INC.","filed_at":"2023-07-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.351654+00:00","generated_at":"2026-06-13T05:26:02.324885+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Bio-Rad authorizes new $500M share repurchase program, superseding prior $650M program","bullets":["Board authorized up to $500M in common stock repurchases; no time limit.","Prior $650M repurchase program was completed on June 5, 2023.","Repurchases at management's discretion on open market or privately.","Acquired shares for employee stock plans, acquisitions, and dilution offset."],"urls":{"canonical":"https://secwatch.observer/filing/0000012208-23-000058","json":"https://secwatch.observer/filing/0000012208-23-000058.json","markdown":"https://secwatch.observer/filing/0000012208-23-000058.md","text":"https://secwatch.observer/filing/0000012208-23-000058.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000058/0000012208-23-000058-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/12208/000001220823000058/bio-20230720.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T05:26:02.324885+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}